Scandion Oncology A/S announced that Michel Ducreux, board member since May 2024 is stepping down from his position. Ducreux is also co-chair of the European Society For Medical Oncology Gastrointestinal Congress 2024 and 2025 organization and member of the clinical guidelines committee. He is stepping down due to the scientific society?s guidelines prohibiting such board positions.

Michel Ducreux, MD, PhD, will continue to support Scandion in an advisory role on the company?s advisory board, where his extensive knowledge and expertise can continue to benefit Scandion.